Advanced Renal Cell Cancer and Low-Dose Palliative Radiation Treatment: A Case of a Substantial and Sustained Treatment Response
Clear cell carcinoma is the most common form of renal cell carcinoma (RCC). Metastatic RCC is poorly responsive to treatment and has a bleak prognosis. Newer systemic agents have improved outcomes. Furthermore, their interaction with radiation treatment (RT) may provide further therapeutic options....
Main Authors: | Kirsten van Gysen, Andrew Kneebone, Thomas Eade, Alexander Guminski, George Hruby |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2018-11-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/493913 |
Similar Items
-
Contemporary treatment of metastatic renal cell carcinoma
by: Igor Stukalin, et al.
Published: (2016-07-01) -
Embolization of the Renal Artery in Combined Treatment of Stage IV Kidney Cancer
by: Sh. Kh. Gantsev, et al.
Published: (2020-11-01) -
Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma
by: Zu‐Yau Lin, et al.
Published: (2021-07-01) -
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
by: Pierangela Sepe, et al.
Published: (2021-07-01) -
Palliative Radiation Therapy for Symptomatic Control of Inoperable Renal Cell Carcinoma
by: Anatoly Nikolaev, et al.
Published: (2016-01-01)